OWASP MASVS-aligned mobile testing - local data storage, network communication, platform interaction, and binary protections.
The short answer
Mobile app penetration testing checks iOS and Android companion apps for weaknesses: data stored insecurely on the phone, weak network encryption or certificate checks, exposed secrets in the app code, and flaws in how the app pairs with and commands the device. Because the app often controls the device, findings are traced to the threat model and rated for patient-harm risk.
275+ devices supported. No cybersecurity-related rejections to date.
A medical-device companion app is rarely just a UI. It carries pairing material, holds patient data at rest, brokers BLE traffic, and talks to a cloud API that often has more privilege than the device itself.
Layers shown outermost (top) to innermost (bottom). Dashed rows are part of the surrounding system but out of scope for this view.
Every mobile application penetration testing engagement ships with the artifacts FDA reviewers expect to see - traceable, complete, and aligned with current guidance.
Recalls, CISA ICS-MA advisories, and disclosed research that shape what reviewers ask about - and what this engagement is built to cover.
See how this service applies to your specific MedTech segment.
OWASP MASVS-aligned mobile testing - local data storage, network communication, platform interaction, and binary protections.
